Izeltabart

For research use only. Not for therapeutic Use.

  • CAT Number: I040390
  • CAS Number: 2642078-60-0
  • Purity: ≥95%
Inquiry Now

Izeltabart(CAT: I040390) is a high-affinity humanized IgG1κ monoclonal antibody specifically designed to target ADAM9, a metalloproteinase commonly overexpressed in various solid tumors. Optimized for precise conjugation, Izeltabart serves as the antibody backbone for ADC development, notably IMGC‑936, an antibody–drug conjugate incorporating a maytansinoid payload via the DM21‑C linker. This ADC demonstrates potent cytotoxic effects against ADAM9-positive cancer cell lines and significant anti-tumor activity in xenograft models. Supplied as a colorless to light-yellow liquid at ≥ 95% purity, and suitable for site-specific conjugation, Izeltabart is ideal for advanced oncology research, ADC design, tumor-targeted therapy development, and mechanistic cancer studies.

Request a Quote